We are live on ! Find out more
CC

Clearline Capital Portfolio holdings

AUM $1.93B
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+38.13%
3 Year Est. Return
+17.96%
5 Year Est. Return
-8.68%
10 Year Est. Return
-18.93%
AUM
$559M
AUM Growth
-$277M
Cap. Flow
-$334M
Cap. Flow %
-59.78%
Top 10 Hldgs %
38.68%
Holding
164
New
22
Increased
27
Reduced
36
Closed
43

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$9.41M
2
ALIT icon
Alight
ALIT
+$6.95M
3
CRM icon
Salesforce
CRM
+$6.38M
4
HTZ icon
Hertz
HTZ
+$6.21M
5
ATVI
Activision Blizzard
ATVI
+$5.55M

Top Sells

Rank Stock Value
1
ADEA icon
Adeia
ADEA
+$53.2M
2
AMZN icon
Amazon
AMZN
+$17.2M
3
WSC icon
WillScot Mobile Mini Holdings
WSC
+$16.9M
4
WIX icon
WIX.com
WIX
+$15.3M
5
CAH icon
Cardinal Health
CAH
+$13.4M

Sector Composition

Rank Sector Weight
1 Technology 31.74%
2 Industrials 18.2%
3 Healthcare 17.34%
4 Communication Services 16.81%
5 Consumer Staples 5.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYXT
101
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
$550K 0.1%
286,426
+71,003
+33% +$168K
NAUT icon
102
Nautilus Biotechnolgy
NAUT
$152M
$477K 0.09%
264,903
– –
QSI icon
103
Quantum-Si Incorporated
QSI
$166M
$388K 0.07%
211,900
– –
LYRA
104
DELISTED
LYRA THERAPEUTICS INC
LYRA
$374K 0.07%
2,383
– –
ORGNW
105
DELISTED
Origin Materials Inc Warrants
ORGNW
$373K 0.07%
428,993
– –
ACVA icon
106
ACV Auctions
ACVA
$1.43B
$344K 0.06%
41,956
– –
RCEL icon
107
Avita Medical
RCEL
$142M
$332K 0.06%
50,343
– –
CTMX icon
108
CytomX Therapeutics
CTMX
$701M
$315K 0.06%
196,583
– –
PAYO icon
109
Payoneer
PAYO
$2.42B
$293K 0.05%
53,522
– –
PAY icon
110
Paymentus
PAY
$4.29B
$203K 0.04%
25,390
-3,689
-13% -$36.2K
CGNT icon
111
Cognyte Software
CGNT
$657M
$199K 0.04%
63,873
-228,115
-78% -$670K
ECVT icon
112
Ecovyst
ECVT
$1.35B
$161K 0.03%
+18,183
New +$168K
LNSR icon
113
LENSAR
LNSR
$65.7M
$157K 0.03%
52,950
– –
VATE icon
114
INNOVATE Corp
VATE
$106M
$147K 0.03%
7,876
– –
NRDY.WS
115
DELISTED
Nerdy Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
NRDY.WS
$117K 0.02%
510,400
– –
SIOX
116
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$109K 0.02%
250,024
-142,667
-36% -$46.3K
VINC
117
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$101K 0.02%
4,946
-17,663
-78% -$333K
ORGN
118
DELISTED
Origin Materials
ORGN
$91.2K 0.02%
659
– –
ACHV icon
119
Achieve Life Sciences
ACHV
$634M
$66.5K 0.01%
27,156
-92,938
-77% -$238K
NUVB.WS
120
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$4.81K ﹤0.01%
33,271
– –
ADMA icon
121
ADMA Biologics
ADMA
$2.04B
– –
-2,496,297
Closed -$6.07M
AIR icon
122
AAR Corp
AIR
$5.62B
– –
-60,802
Closed -$2.18M
ATR icon
123
AptarGroup
ATR
$8.8B
– –
-12,554
Closed -$1.19M
OPTU
124
Optimum Communications Inc
OPTU
$298M
– –
-658,658
Closed -$3.84M
BLKB icon
125
Blackbaud
BLKB
$1.65B
– –
-137,768
Closed -$6.07M
3 4
5
6 7

Similar funds

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

Clearline Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Clearline Capital held 164 positions worth $559M, down 33% from $836M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Clearline Capital withdrew a net $334M in Q4 2022, closing 43 positions and reducing 36 holdings. Its most notable exit was Cardinal Health, an estimated $13.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Clearline Capital opened a new position in Tesla worth $6.12M.

  • Clearline Capital's largest Q4 2022 buy was Tesla: 49,680 shares worth $6.12M.
  • Clearline Capital added most to Alight in Q4 2022, an estimated $6.95M increase.
  • Clearline Capital's biggest Q4 2022 reduction was Adeia, cutting an estimated $53.2M.
  • Clearline Capital fully exited Cardinal Health in Q4 2022, selling an estimated $13.4M.
  • Clearline Capital's ten largest holdings make up 39% of its $559M portfolio in Q4 2022.
  • Clearline Capital opened 22 new positions and closed 43 in Q4 2022.
  • Clearline Capital's portfolio value fell 33% quarter-over-quarter to $559M.

Based on Clearline Capital's 13F filing for Q4 2022, filed 14 Feb 2023.